BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21762073)

  • 1. Ceramide in chemotherapy of tumors.
    Dimanche-Boitrel MT; Rebillard A; Gulbins E
    Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):284-93. PubMed ID: 21762073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceramide-induced cell death in malignant cells.
    Carpinteiro A; Dumitru C; Schenck M; Gulbins E
    Cancer Lett; 2008 Jun; 264(1):1-10. PubMed ID: 18353542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the ceramide system in cancer.
    Henry B; Möller C; Dimanche-Boitrel MT; Gulbins E; Becker KA
    Cancer Lett; 2013 May; 332(2):286-94. PubMed ID: 21862212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide synthesis and metabolism as a target for cancer therapy.
    Reynolds CP; Maurer BJ; Kolesnick RN
    Cancer Lett; 2004 Apr; 206(2):169-80. PubMed ID: 15013522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of ceramide metabolism in T-leukemia cell lines potentiates apoptosis induced by the cationic antimicrobial peptide bovine lactoferricin.
    Furlong SJ; Ridgway ND; Hoskin DW
    Int J Oncol; 2008 Mar; 32(3):537-44. PubMed ID: 18292930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance.
    Ogretmen B; Hannun YA
    Drug Resist Updat; 2001 Dec; 4(6):368-77. PubMed ID: 12030784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly-drug cancer therapy based on ceramide.
    Radin NS
    Eksp Onkol; 2004 Mar; 26(1):3-10. PubMed ID: 15112572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological aspects of ceramide-enriched membrane domains.
    Grassmé H; Riethmüller J; Gulbins E
    Prog Lipid Res; 2007; 46(3-4):161-70. PubMed ID: 17490747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingolipids and response to chemotherapy.
    Dimanche-Boitrel MT; Rebillard A
    Handb Exp Pharmacol; 2013; (216):73-91. PubMed ID: 23563652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells.
    Qiu L; Zhou C; Sun Y; Di W; Scheffler E; Healey S; Wanebo H; Kouttab N; Chu W; Wan Y
    Oncol Rep; 2006 Oct; 16(4):907-13. PubMed ID: 16969513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressive functions of ceramide: evidence and mechanisms.
    Galadari S; Rahman A; Pallichankandy S; Thayyullathil F
    Apoptosis; 2015 May; 20(5):689-711. PubMed ID: 25702155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma.
    Rath G; Schneider C; Langlois B; Sartelet H; Morjani H; Btaouri HE; Dedieu S; Martiny L
    Int J Biochem Cell Biol; 2009 May; 41(5):1165-72. PubMed ID: 19027085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming resistance to gamma-rays in squamous carcinoma cells by poly-drug elevation of ceramide levels.
    Alphonse G; Bionda C; Aloy MT; Ardail D; Rousson R; Rodriguez-Lafrasse C
    Oncogene; 2004 Apr; 23(15):2703-15. PubMed ID: 15048093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceramide and glutathione define two independently regulated pathways of cell death initiated by p53 in Molt-4 leukaemia cells.
    El-Assaad W; Kozhaya L; Araysi S; Panjarian S; Bitar FF; Baz E; El-Sabban ME; Dbaibo GS
    Biochem J; 2003 Dec; 376(Pt 3):725-32. PubMed ID: 12967322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
    Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
    Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer.
    Selzner M; Bielawska A; Morse MA; Rüdiger HA; Sindram D; Hannun YA; Clavien PA
    Cancer Res; 2001 Feb; 61(3):1233-40. PubMed ID: 11221856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killing tumours by ceramide-induced apoptosis: a critique of available drugs.
    Radin NS
    Biochem J; 2003 Apr; 371(Pt 2):243-56. PubMed ID: 12558497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sphingolipid-mediated apoptotic signaling pathways].
    Cuvillier O; Andrieu-Abadie N; Ségui B; Malagarie-Cazenave S; Tardy C; Bonhoure E; Levade T
    J Soc Biol; 2003; 197(3):217-21. PubMed ID: 14708343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin mediates ceramide generation via the de novo pathway in colon cancer cells.
    Moussavi M; Assi K; Gómez-Muñoz A; Salh B
    Carcinogenesis; 2006 Aug; 27(8):1636-44. PubMed ID: 16501251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular targeting therapy for leukemia by sphingolipid ceramide].
    Okazaki T
    Rinsho Byori; 2005 May; 53(5):413-21. PubMed ID: 15966405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.